TR200000635T2 - Levosimendan'ın oral kompozisyonları. - Google Patents

Levosimendan'ın oral kompozisyonları.

Info

Publication number
TR200000635T2
TR200000635T2 TR2000/00635T TR200000635T TR200000635T2 TR 200000635 T2 TR200000635 T2 TR 200000635T2 TR 2000/00635 T TR2000/00635 T TR 2000/00635T TR 200000635 T TR200000635 T TR 200000635T TR 200000635 T2 TR200000635 T2 TR 200000635T2
Authority
TR
Turkey
Prior art keywords
levosimendan
oral compositions
polymorphic form
essentially
useful
Prior art date
Application number
TR2000/00635T
Other languages
English (en)
Inventor
Harjula Maarit
Lehtonen Lasse
Antila Saila
Larma Ilkka
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of TR200000635T2 publication Critical patent/TR200000635T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Farmasötik olarak kabul edilebilen bir tasiyici ile birlikte, aktif bir muhteviyat olarak levosimendan'in esasen saf kristal polimorfik formundan (I) olusan, oral yolla ilaç olarak verilmesi için bir kompozisyon tanimlanmaktadir. Levosimendan'in polimorfik formu, gastrointestinal bölgeden hizlica abzorbe edilmektedir ve kongestif kalp yetmezliginin tedavisinde faydalidir.
TR2000/00635T 1997-09-26 1998-09-24 Levosimendan'ın oral kompozisyonları. TR200000635T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI973804A FI973804A7 (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia

Publications (1)

Publication Number Publication Date
TR200000635T2 true TR200000635T2 (tr) 2000-09-21

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00635T TR200000635T2 (tr) 1997-09-26 1998-09-24 Levosimendan'ın oral kompozisyonları.

Country Status (35)

Country Link
US (1) US6355269B1 (tr)
EP (1) EP1014987B1 (tr)
JP (1) JP4493840B2 (tr)
KR (1) KR100762022B1 (tr)
CN (1) CN1149994C (tr)
AR (1) AR013519A1 (tr)
AT (1) ATE260659T1 (tr)
AU (1) AU732489B2 (tr)
BG (1) BG64746B1 (tr)
BR (1) BR9813213A (tr)
CA (1) CA2304702C (tr)
CZ (1) CZ294984B6 (tr)
DE (1) DE69822172T2 (tr)
DK (1) DK1014987T3 (tr)
EA (1) EA001647B1 (tr)
EE (1) EE03854B1 (tr)
ES (1) ES2217580T3 (tr)
FI (1) FI973804A7 (tr)
GE (1) GEP20032943B (tr)
HR (1) HRP20000171B1 (tr)
HU (1) HUP0003757A3 (tr)
ID (1) ID24486A (tr)
IL (1) IL134802A (tr)
MX (1) MXPA00002956A (tr)
MY (1) MY118156A (tr)
NO (1) NO320047B1 (tr)
NZ (1) NZ503207A (tr)
PL (1) PL190862B1 (tr)
PT (1) PT1014987E (tr)
RS (1) RS49708B (tr)
SI (1) SI1014987T1 (tr)
SK (1) SK283187B6 (tr)
TR (1) TR200000635T2 (tr)
WO (1) WO1999016443A1 (tr)
YU (1) YU17700A (tr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980902A7 (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A7 (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
WO2002055059A2 (en) 2000-12-22 2002-07-18 Baxter Int Method for preparing submicron particle suspensions
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
US9000158B2 (en) 2009-07-14 2015-04-07 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
EP4076398B1 (en) * 2019-12-16 2026-02-18 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hf-pef)
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
FI973804A0 (fi) 1997-09-26
KR100762022B1 (ko) 2007-09-28
US6355269B1 (en) 2002-03-12
SK283187B6 (sk) 2003-03-04
HRP20000171A2 (en) 2000-12-31
EA200000360A1 (ru) 2000-10-30
HUP0003757A3 (en) 2001-07-30
AR013519A1 (es) 2000-12-27
EP1014987B1 (en) 2004-03-03
PL339461A1 (en) 2000-12-18
EA001647B1 (ru) 2001-06-25
CZ294984B6 (cs) 2005-04-13
MXPA00002956A (es) 2003-05-19
SI1014987T1 (en) 2004-08-31
MY118156A (en) 2004-09-30
JP2001517702A (ja) 2001-10-09
EE200000187A (et) 2001-04-16
EE03854B1 (et) 2002-10-15
YU17700A (sh) 2002-10-18
BG104250A (en) 2000-12-29
PT1014987E (pt) 2004-06-30
FI973804A7 (fi) 1999-03-27
NO20001585L (no) 2000-03-27
DE69822172D1 (de) 2004-04-08
NZ503207A (en) 2001-04-27
PL190862B1 (pl) 2006-02-28
CA2304702A1 (en) 1999-04-08
WO1999016443A1 (en) 1999-04-08
SK3842000A3 (en) 2000-09-12
BR9813213A (pt) 2000-08-29
HRP20000171B1 (en) 2009-06-30
HUP0003757A2 (hu) 2001-05-28
KR20010030679A (ko) 2001-04-16
ID24486A (id) 2000-07-20
BG64746B1 (bg) 2006-02-28
CN1271282A (zh) 2000-10-25
NO20001585D0 (no) 2000-03-27
HK1032001A1 (en) 2001-07-06
IL134802A0 (en) 2001-04-30
JP4493840B2 (ja) 2010-06-30
AU9350698A (en) 1999-04-23
CA2304702C (en) 2007-09-04
IL134802A (en) 2004-01-04
EP1014987A1 (en) 2000-07-05
ATE260659T1 (de) 2004-03-15
RS49708B (sr) 2007-12-31
ES2217580T3 (es) 2004-11-01
DE69822172T2 (de) 2005-02-24
GEP20032943B (en) 2003-04-25
CZ2000919A3 (cs) 2000-09-13
AU732489B2 (en) 2001-04-26
CN1149994C (zh) 2004-05-19
DK1014987T3 (da) 2004-05-24
NO320047B1 (no) 2005-10-17

Similar Documents

Publication Publication Date Title
TR200000635T2 (tr) Levosimendan'ın oral kompozisyonları.
CA2368347A1 (en) Glucokinase activators
DE69829175D1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EA200100838A1 (ru) Конъюгаты гксф
CA2245142A1 (en) New phenanthridines
TR199800697T2 (tr) Farmasötik olarak aktif kinazolin bilesimleri.
TR199902995T2 (tr) 9-Oksim eritromisin türevleri
PL358103A1 (pl) Hydrofilowe molekularne roztwory dyspersyjne karwedilolu
GR3031233T3 (en) Selective system scan for multizone radiotelephone subscriber units.
ATE58292T1 (de) L-dopa enthaltendes arzneimittel.
TR200102385T2 (tr) Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.
DE69720551D1 (de) Makrozyklische derivate von erythromycin a und b mit 13 ringatomen
ATE311227T1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
TR200103460T2 (tr) 5-Fenil-pirimidin türevleri
TR199802102T2 (tr) Antifungal madde ve asetat tampon maddesi içeren bilesimler.
DK0615754T3 (da) Faste flupertinholdige orale administrationsformer med kontrolleret frigivelse af den aktive forbindelse
DE59800863D1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
TR200001869T2 (tr) Terapetik Maddeler
PT781126E (pt) Derivados de 2-amino-1,2,3,4-tetra-hidro naftalino activos no sistema cardiovascular
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
TR200401462T4 (tr) Torsemid modifikasyonu II' yi içeren dengeli bir farmasötik formülasyonu
IT1289979B1 (it) 5-idrossimetil-6-idrossi-2-amminotetraline attive come agenti cardiovascolari
BR9710377A (pt) Gr-nulos de derivados de hexahidropirazina administr veis por via oral
TR200000005T2 (tr) Sıtmaya karşı ß-alkoksiakrilatlar.